QRG Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

QRG Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.98M	Buy	372,752 +5,064	+1%	+$83.8K	0.05%	280
2026 Q1	$6.81M	Buy	367,688 +78,958	+27%	+$1.39M	0.07%	240
2025 Q4	$4.5M	Buy	288,730 +7,587	+3%	+$108K	0.05%	269
2025 Q3	$4.12M	Sell	281,143 -151,511	-35%	-$2.25M	0.05%	270
2025 Q2	$6.69M	Buy	432,654 +45,726	+12%	+$676K	0.06%	262
2025 Q1	$5.75M	Buy	386,928 +57,284	+17%	+$803K	0.06%	280
2024 Q4	$4.36M	Buy	329,644 +47,490	+17%	+$652K	0.04%	309
2024 Q3	$4.01M	Buy	282,154 +12,035	+4%	+$171K	0.04%	319
2024 Q2	$3.5M	Sell	270,119 -46,649	-15%	-$618K	0.04%	323
2024 Q1	$4.4M	Sell	316,768 -4,541	-1%	-$66K	0.06%	286
2023 Q4	$4.59M	Sell	321,309 -34,932	-10%	-$496K	0.07%	274
2023 Q3	$5.51M	Buy	+356,241	New	+$5.51M	0.1%	215

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

QRG Capital Management's TAK Position: Q2 2026 in Review

QRG Capital Management increased its Takeda Pharmaceutical (TAK) stake by 1.4% in Q2 2026, buying an estimated $83.8K and bringing the position to 372,752 shares worth $5.98M. The position accounts for 0.05% of the portfolio, ranked #280.

QRG Capital Management first reported a position in TAK in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.81M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

QRG Capital Management held 372,752 shares of Takeda Pharmaceutical worth $5.98M as of Q2 2026.
QRG Capital Management bought 5,064 Takeda Pharmaceutical shares in Q2 2026, an estimated $83.8K.
Takeda Pharmaceutical made up 0.05% of QRG Capital Management's portfolio in Q2 2026, its #280 holding.
QRG Capital Management first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's Takeda Pharmaceutical position peaked at $6.81M in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.